Novartis launches ‘no profit’ COVID-19 drugs for low-income countries
BASEL: The Basel-based drugmaker company has announced not to make a profit on 15 generic drugs it is making available to developing countries to treat symptoms of COVID-19. Novartis company said that it would provide medicines ranging from antibiotics and